ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645621 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645621; 2) Community: the network communities that were significantly associated with the response to NSC 645621; 3) Molecule: the relationships between components within communities and NSC 645621; 4) MDR: the compounds that were significantly associated with the NSC 645621.

NSC Compound Enrichment Correlation
NSC 327182 L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- 0.0312262198176283 -0.057406709
NSC 351907 MASTOPARAN 0.0312262198176283 0.15331758
NSC 600684 Null 0.0312262198176283 0.52281692
NSC 628141 Null 0.0312262198176283 0.4713494
NSC 703442 Null 0.0352383000003052 0.19462414
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0352383000003056 0.23790998
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.0352383000003056 0.18446612
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0352383000003056 0.17646947
NSC 328784 1-Piperazinecarboselenoic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)ethylidene]hydrazide 0.0352383000003056 0.18967301
NSC 33570 Null 0.0352383000003056 0.23633851
Total:56  Current:35    [First] [Prev] [Next] [Last]